A Phase IIa Study in Primary IgA Nephropathy Patients | MicrobiomeTrials← Back to trialsNCT07634744
A Phase IIa Study in Primary IgA Nephropathy Patients
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-12-31Est. Completion: 2026-04-23
Enrollment target: 25 participants Locations- Peking University First Hospital, Beijing, China
Other microbiome trials you might be interested in
Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN
This is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults …
Shenzhen, ChinaEst. completion Jul 10, 2028
Lupus Nephritis (LN)
This study is researching a particular group of experimental drugs administered for a short period in the treatment of p…
Rochester, United StatesEst. completion Sep 9, 2029